Al-Sharaa to Asharq Al-Awsat: Revolution Ended with Regime’s Fall, Will Not Be Exported

Ahmed Al-Sharaa in the interview with Bissane El-Cheikh in Damascus on Thursday
Ahmed Al-Sharaa in the interview with Bissane El-Cheikh in Damascus on Thursday
TT

Al-Sharaa to Asharq Al-Awsat: Revolution Ended with Regime’s Fall, Will Not Be Exported

Ahmed Al-Sharaa in the interview with Bissane El-Cheikh in Damascus on Thursday
Ahmed Al-Sharaa in the interview with Bissane El-Cheikh in Damascus on Thursday

Ahmed Al-Sharaa, the head of the new Syrian administration, told Asharq Al-Awsat that “the Syrian revolution ended with the regime's fall, and we will not allow it to spread elsewhere.”

He stressed that Syria “will not be used to attack or destabilize any Arab or Gulf country.”

Speaking from the Presidential Palace in Damascus on Thursday, Al-Sharaa said the Syrian opposition’s actions had “set the Iranian project in the region back by 40 years.”

Asked why Syria has yet to send a direct message to the Gulf and major Arab nations, Al-Sharaa responded by saying that his country has much to say to its Arab neighbors.

“Syria had become a platform for Iran to control key Arab capitals, spread wars, and destabilize the Gulf with drugs like Captagon,” he said.

He added: “By removing Iranian militias and closing Syria to Iranian influence, we’ve served the region’s interests—achieving what diplomacy and external pressure could not, with minimal losses.”

Al-Sharaa also criticized efforts to restore ties with the former Syrian regime, including its return to the Arab League in exchange for concessions.

“We were confident this would fail because we knew the regime would not make any genuine concessions or approach these overtures in good faith,” he said.

He claimed that during a meeting with Jordanian officials, the former regime was asked why it insisted on exporting Captagon to Jordan.

“The response was that it would not stop unless sanctions were lifted," Al-Sharaa said, adding “this is not how the regime operates.”

He emphasized that Gulf strategic security has since improved. “Today, the Iranian project in the region has been pushed back 40 years, making the Gulf more secure and stable.”

When asked if he would give reassurances on Syria not becoming a refuge for certain figures, Al-Sharaa dismissed concerns about hosting figures who cause concern for some Arab nations, saying Syria will not become a haven for controversial individuals.

“We are now focused on state-building. The revolution ended with the regime's fall, and we will not allow it to spread elsewhere. Syria will not be a platform to threaten or unsettle any Arab or Gulf country,” he said.

Al-Sharaa stressed that Syria seeks to rebuild and strengthen ties with Arab nations. “Syria is tired of wars and being used for others’ agendas. We want to restore trust and rebuild our country as part of the Arab world.”

He praised the Gulf’s progress, saying: “We admire the development in Gulf countries, particularly Saudi Arabia’s bold plans and vision, and we aspire to achieve similar progress for Syria.”

He added: “There are many opportunities for cooperation, especially in economic and developmental areas, where we can align our goals.”

On Syria’s relationship with its neighbor Lebanon, Al-Sharaa acknowledged concerns raised by Lebanese counterparts about him reaching Damascus, fearing it could strengthen one faction over another in Lebanon.

“We are not seeking any form of dominance over Lebanon,” he said. “We want a relationship based on mutual respect and exchange, without interfering in Lebanon’s internal affairs. We have enough work to do in our own country.”

Al-Sharaa emphasized Syria’s intention to maintain balanced relations, saying he aims “to stand equally with all Lebanese groups, and what pleases them, pleases us.”

Al-Sharaa was asked about a national dialogue conference and a new constitution to guide Syria’s future, and the mechanism that he plans to ensure inclusivity for all Syrians in the process, especially among the base of supporters and fighters who do not necessarily agree with his current moderate speech.

Al-Sharaa acknowledged differing opinions but emphasized he does not want to impose his personal views on Syrians.

“I believe in letting legal experts shape the relationship between citizens, with the law as the guide,” he said.

“Syria is diverse, and it's natural for there to be different opinions. This difference is healthy.”

Al-Sharaa stressed that the recent victory is for all Syrians, not one group over another.

“Even those we thought were loyal to the old regime expressed joy, as they had not been able to openly express their feelings before,” he noted.

He expressed confidence that Syrians, regardless of their background, are aware enough to protect their country.

“My aim is to reach a broad agreement and build a country where the rule of law helps resolve our differences,” Al-Sharaa concluded.

On the complex issue of forced disappearances and individuals missing in prisons and mass graves, Al-Sharaa said the previous regime was a criminal gang, not a political system.

“We fought a brutal group that committed crimes like arrests, forced disappearances, killings, displacement, starvation, chemical attacks, and torture,” he said.

He stressed that while the regime is gone, the focus should be on justice, not revenge.

“We must not approach this with a desire for vengeance,” he said.

Al-Sharaa stated that those responsible for crimes like the Saydnaya prison and chemical attacks must be held accountable.

“Their names are known and they must be pursued,” he said. He also affirmed that families have the right to file complaints against unknown perpetrators.

Al-Sharaa outlined efforts to address the issue of missing persons. “We’ve broken the barriers, and specialized organizations are now helping with this task,” he said.

A new ministry will be set up to track the fate of the missing, both the deceased and the living.

“This will also assist families with documents like death certificates and inheritance,” he added.

He acknowledged the challenge ahead but emphasized the need to uncover the truth. “This is a big task, but we must find the truth,” Al-Sharaa said.

When asked about hosting the interview at the People’s Palace, the same location where Bashar al-Assad once sat, Al-Sharaa responded with a light-hearted laugh.

“To be honest, I don’t feel comfortable at all,” he said. “But this is a place that should be open to the people, a site where they can visit and where children can play in these courtyards.”



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.